Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
So 4 trading days now till interims.it will have been 5 months since any comment on the SPA process. i don't see how they can avoid saying something in the interims. if it is dead in the water surely they will have to come clean.hoping that is not the case,but not feeling confident.
"Friend", eh. Bothwell- real, imaginary or did contact involve a Ouija board?
And if real, do you happen to be on the same medication?
Afternoon all. i hope you are wrong,bignose,re cash call but expect you are correct. only thing that could possibly prevent it would be an fda partner, but really can't see that happening now, with the continuing radio silence re SPA. looking like we may need to pin all our hopes on china.
I for one am anxious about the FDA since incompetence rules. One just has to reread all the announcements and emails received where lies have been openly made and miss information passed on to understand what a complete cokc-up the company has made regarding the approval process which leave me with the bad taste that they may have missed the boat.
The Chinese approval process, however, is going according to plan as the process has no connection with the monkeys running the company. I fully expect approval mid next year.
That said, I fully expect another cash call with further dilution as they will have no money, yet again, come the end of the year. A totally unnecessary requirement if they had gotten their act together several years back. What a complete disaster management have been. Led by a chairman who has absolutely no business sense in this area. A person who should have replaced the bod and ceo with experienced and competence people from the very beginning.
I’m all for being optimistic bothwell, but is there any reason we should value your friends opinion on the matter ? We all seem to be in the lurch here just hoping
I was in contact with my friend and he thinks USA and China will happen. He has sunk a lot of money into this over the years!
Too true,bignose. certainly expected to have heard before now.not a good feeling..i see we have the interims' date now.
Morning The.Italian,
I’m afraid it’s going to be flip of the coin on FDA news. Something certainly doesn’t seem right. It really shouldn’t be taking this long. It’s not like the FDA has reams of data to go through. Just less than 90 subject data, yet 5 plus years to pass the phase II finish and its still not done, sumfings up
Interesting post re china.thanks.yes maybe that has taken a bit longer than expected. it's the fda position which really concerns me.still getting closer to interims day and some news at least.
And still no update or obvious progress on the FDA submission which is still stuck on Sept 22. Another few weeks and it will be over a year since the results were first submitted. What a debacle it has been from the start.
https://classic.clinicaltrials.gov/ct2/show/NCT03578783
I notice the gov website for the phase 3 is now showing completed. it was only a month or two ago, last time I looked, that it wasn't showing phase III as fully "completed" but instead had some other dialogue there (cannot remember what was written but i know it wasn't just the one word "completed" as per now)
http://www.chinadrugtrials.org.cn/clinicaltrials.searchlist.dhtml
Seems progress is still being made. Maybe that's what caused the recent interest ?
Agree, good to see the end of JO. Did she add much value? She never had much skin in the game unlike JG and JM
Happy to see some new blood on the board but would have preferred a heavy hitter like Dr Wyllie or Dr Zhavoronkov both with solid industry experience, oh well
Perhaps they are looking to him to assist with the DLI aspect (SaaS?), but more likely he just fits the bill as a suitably biddable ind to aid with the occasional rubber stamping exercise. lol!
looking like we may have to wait for interims for any substantive news.
Finally after years of realisation that she has no experience in Pharma, Julie Oates has left to get her Oats elsewhere, although god knows what she did in the company apart from get paid.
And what do they do with an opportunity to right their wrongs and employ someone with relevant background, they employ someone with a mainly engineering background who’s names resembles a bottle of wine, Al Chalabi.
What’s the matter with these people ? Surely they must have realised by now the company desperately needs talent with Pharma experience. Maybe they employed him because they think the company is going to fly after Chinese submission……oh dear, oh dear….
H,
I certainly am not an HSBC trader, in fact nothing to do with my profession when I worked. Pure guesswork on your side I’m afraid, but all means keep trying.
I doubt it is a simple pump and dump but rather accumulation by Haitong Securities during the past 3 weeks.
It is not uncommon for prof investors to sell a few shares during the accumulation phase in order to keep
the sp within a low trading band (fx. buy 40-50,000 then quickly dump 10,000..).
The share was sold down to a historical low of just 25c on very low volume so it should recover on low vol.
News on the NDA submission is not far away now and should get the sp moving.
I noticed an erratic 500k sell order @ 72c about 4-5 weeks ago, was that you Bignose, you are a HSBC trader right?
Morning bignose.yes i had to laugh.now my prediction for the lottery results is....
i did wonder about a p&d, but not really much volume.i suspect it is more a function of the larger required lot sizes and the fact that mellon and cohorts own almost 60%. that is going to make the s/p more sensitive with reduced free float. at least that is my theory, but as we all know i'm no expert.
Amazingly, it was up over 25% and a couple of 10single lot sells brings it back down with a thump. At least the sp managed to hold on to 11%.
Could this just be a low volume pump and dump (if there is such a thing) heading into the mid term results, what say you H ?
The.Italian,
You were not wrong. A sudden rise and right on cue, Heimdal enters stage left.
Let’s all give it up for Heimdal…clap, clap, clap….hoooorrraaahhh.
"7/6/23 0.59 hkd the low." Not correct, Ripley. I picked up another 50,000 shares @ 25c - now in safe hands.. lol
Interesting accumulation during the last few weeks by Haitong Securities
Ripely,
You may want to consider dipping a toe in FUM since their mid-term results are due in Sept which could give a sudden boost, although maybe risky given the US license agreement held no juice, however. One would expect in the long term the sp could do well as more license agreements are signed and first impressions are that the product is definitely giving Viagra and Cialis a run for their money which, in a multi-billion dollar market, cannot be ignored.
Bignose58 I did not have just share holders who might also read this site in mind.
Morning The.Italian.
No problem, the guy obviously hasn't read any of your posts. He doesn't even know if you are supposedly ramping or deramping. A complete dcik
Morning bignose.we are indeed a very small(but undoubtedly select) band on here. enter heimdal stage left?
thanks for the support on FUM.appreciated.
Ripely, there are no other less experienced investors who post here. The only ones who do are hardened investors (except 1) who have followed the stock since the Ple takeover at the beginning of 2016. The majority of investors outside of the A team are those residing in HK or mainland China and then those that have posted here have turned out to be English speaking HK traders who think they can manipulate the stock when they are involved in pumps and dumps, however. Given how the free float is now a lot less, I would suspect that it’s become more difficult for them to even do that.